The retrieved data included study characteristics, characteristics of patients, interventions, and outcome measures, that included the hazard ratios (HR) and confidence intervals (CI) for cardiorenal outcomes
"This risk is present when patients are not trying to lose weight, as well as when they may be trying to
Drug effects on the nervous system: Mechanisms and future directions in neuropharmacological therapy
Moreover, as illustrated in Figure 15, the binding pattern of SR18 with GLP-1R resembles that of two other reported GLP-1RAs, such as Orforglipron (LY3502970) and peptide 5 (10 aa)
Standard criteria for approval include a BMI of 30 kg/m or greater, or a BMI of 27 kg/m or greater with at least one weight-related comorbidity such as type 2 diabetes, hypertension, or obstructive sleep apnea [4]